Special Lunchtime Event with FDA Representative Dr. Seyfert-Margolis!
The FDA is taking steps to drive biomedical innovation while improving the health of Americans. Oregon's Bioscience Industry is an intregral part of this initiative. The first BioForm of 2012 will discuss the FDA's blueprint for these process changes and how the changes pertain to Oregon's Bioscience Industry.
The FDA Initiative includes:
- Rebuilding FDA’s small business outreach services
- Building the infrastructure to drive and support personalized medicine
- Creating a rapid drug development pathway for important targeted therapies
- Harnessing the potential of data mining and information sharing while protecting patient privacy
- Improving consistency and clarity in the medical device review process
- Training the next generation of innovators
- Streamlining and reforming FDA regulations
To download the full initiative, click here.
Speaker: Dr. Seyfert-Margolis Vicki L.
 Seyfert-Margolis, Ph.D., is the Senior Advisor for Science Innovation and Policy for the FDA Commissioner’s Office. Dr. Seyfert-Margolis focuses on initiatives in regulatory science and innovation, personalized medicine and scientific computing and informatics. Previously, she served as Chief Scientific Officer at Immune Tolerance Network (ITN), a non-profit consortium of researchers seeking new treatments for diseases of the immune system. At ITN, she oversaw the development of more than 20 centralized laboratory facilities, and the design and execution of biomarker discovery studies for over 25 Phase II clinical trials. As part of the biomarker efforts, she established construction of a primer library of 1,000 genes that may be involved in establishing and maintaining immunologic tolerance and co-discovered genes that may mark kidney transplant tolerance. Dr. Seyfert-Margolis was also an Adjunct Associate Professor within the Department of Medicine at the University of California, San Francisco. Prior to academia, she served as Director of the Office of Innovative Scientific Research Technologies at the National Institute of Allergy and Infectious Diseases at NIH, where she worked to integrate emerging technologies into existing immunology and infectious disease programs. Dr. Seyfert-Margolis completed her Ph.D. in immunology at the University of Pennsylvania’s School of Medicine. Dr. Seyfert-Margolis has co-authored numerous publications and has lectured internationally on various topics.
When: Thursday, February 16, 2012 from 11:30 a.m to 1:30 p.m
Where: Schwabe, Williamson and Wyatt, PacWest Center 1211 SW 5th Ave., Portland, OR
Cost: $25 Members, $40 Non-members, $15 Students, registration fee includes lunch.
|